Denmark

Denmark

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.8 (0.60 - 1.03) 2015 Modelled WHO
0.3 (0.20 - 0.30) 2016 Modelled Razavi-Shearer et al, 2018
0.91 (0.87 - 0.95) 2013 Modelled Schweitzer et al, 2015
0.89 (0.74 - 1.05) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.98 (0.82 - 1.16) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.83 - 1.17) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.83 - 1.16) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.83 - 1.16) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.83 - 1.16) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.83 - 1.16) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.82 - 1.16) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.81 - 1.16) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.80 - 1.16) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.80 - 1.15) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.13) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.80 - 1.12) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.79 - 1.11) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.78 - 1.11) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.79 - 1.12) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.79 - 1.13) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.80 - 1.14) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.80 - 1.17) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.80 - 1.18) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.81 - 1.18) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.81 - 1.18) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.81 - 1.17) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.81 - 1.18) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.81 - 1.18) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.81 - 1.18) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.81 - 1.18) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.81 - 1.19) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.81 - 1.19) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.81 - 1.20) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.81 - 1.14) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.79 (0.57 - 1.06) 2015 Modelled WHO
0.37 (0.24 - 0.52) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.65 (0.43 - 0.90) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.47 - 0.98) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.71 (0.49 - 1.03) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.48 - 1.01) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.47 - 1) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.47 - 1) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.46 - 0.98) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.71 (0.45 - 0.97) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.7 (0.44 - 0.96) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.43 - 0.96) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.67 (0.42 - 0.93) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.41 - 0.90) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.40 - 0.87) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.39 - 0.85) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.38 - 0.84) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.39 - 0.85) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.39 - 0.89) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.39 - 0.92) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.63 (0.40 - 0.96) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.63 (0.40 - 1) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.63 (0.40 - 0.99) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.41 - 0.97) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.41 - 0.96) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.42 - 0.95) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.42 - 0.94) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.42 - 0.93) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.42 - 0.91) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.42 - 0.91) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.43 - 0.89) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.42 - 0.87) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.68 (0.59 - 0.79) 2020 Modelled WHO
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.3 (0.20 - 0.30) 2016 Modelled ECDC
0.3 (0.20 - 0.30) 2013 Survey/reported Moller, 2014
0.3 (0.20 - 0.30) 2007 Survey/reported Harder et al, 2011
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
15,000 (14,000 - 19,000) 2016 Modelled Razavi-Shearer et al, 2018
51,442 (42,809 - 60,877) 2019 Modelled IHME, GBD 2019 (accessed 2020)
52,910 (44,113 - 62,503) 2019 Modelled IHME, GBD 2019 (accessed 2022)
53,072 (44,581 - 62,743) 2018 Modelled IHME, GBD 2019 (accessed 2022)
53,085 (44,374 - 62,865) 2017 Modelled IHME, GBD 2019 (accessed 2022)
53,124 (44,361 - 61,938) 2016 Modelled IHME, GBD 2019 (accessed 2022)
53,062 (43,709 - 61,595) 2015 Modelled IHME, GBD 2019 (accessed 2022)
52,696 (43,712 - 61,214) 2014 Modelled IHME, GBD 2019 (accessed 2022)
52,230 (43,490 - 60,782) 2013 Modelled IHME, GBD 2019 (accessed 2022)
51,715 (43,098 - 60,472) 2012 Modelled IHME, GBD 2019 (accessed 2022)
51,191 (42,146 - 60,233) 2011 Modelled IHME, GBD 2019 (accessed 2022)
50,701 (41,471 - 60,169) 2010 Modelled IHME, GBD 2019 (accessed 2022)
50,190 (41,241 - 59,051) 2009 Modelled IHME, GBD 2019 (accessed 2022)
49,623 (41,140 - 58,044) 2008 Modelled IHME, GBD 2019 (accessed 2022)
49,076 (40,691 - 57,272) 2007 Modelled IHME, GBD 2019 (accessed 2022)
48,631 (40,149 - 56,730) 2006 Modelled IHME, GBD 2019 (accessed 2022)
48,351 (39,903 - 56,362) 2005 Modelled IHME, GBD 2019 (accessed 2022)
48,379 (39,835 - 56,473) 2004 Modelled IHME, GBD 2019 (accessed 2022)
48,694 (39,980 - 56,836) 2003 Modelled IHME, GBD 2019 (accessed 2022)
49,113 (40,191 - 57,517) 2002 Modelled IHME, GBD 2019 (accessed 2022)
49,463 (40,332 - 58,496) 2001 Modelled IHME, GBD 2019 (accessed 2022)
49,566 (40,248 - 59,175) 2000 Modelled IHME, GBD 2019 (accessed 2022)
49,412 (40,489 - 59,049) 1999 Modelled IHME, GBD 2019 (accessed 2022)
49,143 (40,406 - 58,456) 1998 Modelled IHME, GBD 2019 (accessed 2022)
48,822 (40,293 - 57,986) 1997 Modelled IHME, GBD 2019 (accessed 2022)
48,531 (39,786 - 57,847) 1996 Modelled IHME, GBD 2019 (accessed 2022)
48,346 (39,660 - 58,116) 1995 Modelled IHME, GBD 2019 (accessed 2022)
48,307 (39,504 - 57,610) 1994 Modelled IHME, GBD 2019 (accessed 2022)
48,382 (39,574 - 57,467) 1993 Modelled IHME, GBD 2019 (accessed 2022)
48,559 (39,459 - 57,545) 1992 Modelled IHME, GBD 2019 (accessed 2022)
48,822 (39,452 - 57,817) 1991 Modelled IHME, GBD 2019 (accessed 2022)
49,165 (39,365 - 58,331) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.69 (2.03 - 3.49) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2.36 (1.76 - 3.11) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.19 (1.62 - 2.88) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2.26 (1.67 - 2.97) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.49 (1.85 - 3.27) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.65 (1.98 - 3.50) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.75 (2.05 - 3.63) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.79 (2.08 - 3.69) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.85 (2.12 - 3.77) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.86 (2.12 - 3.79) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.94 (2.17 - 3.91) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.85 (2.12 - 3.82) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.88 (2.14 - 3.85) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.93 (2.17 - 3.92) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.97 (2.19 - 3.98) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.94 (2.17 - 3.96) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.01 (2.22 - 4.02) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.97 (2.20 - 3.98) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3.02 (2.23 - 4.07) 2007 Modelled IHME, GBD 2019 (accessed 2022)
3 (2.22 - 4.04) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3 (2.22 - 3.99) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.98 (2.23 - 3.93) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.85 (2.17 - 3.72) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.9 (2.19 - 3.81) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.77 (2.11 - 3.64) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.82 (2.14 - 3.70) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.7 (2.05 - 3.51) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.7 (2.02 - 3.56) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.7 (2.04 - 3.52) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.69 (2.03 - 3.49) 2019 Modelled IHME, GBD 2019 (accessed 2022)
2.7 (2.03 - 3.49) 2018 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
116 2016 Modelled WHO
122 (91 - 161) 1992 Modelled IHME, GBD 2019 (accessed 2022)
113 (83 - 148) 1990 Modelled IHME, GBD 2019 (accessed 2022)
116 (86 - 153) 1991 Modelled IHME, GBD 2019 (accessed 2022)
129 (96 - 170) 1993 Modelled IHME, GBD 2019 (accessed 2022)
138 (103 - 182) 1994 Modelled IHME, GBD 2019 (accessed 2022)
144 (107 - 190) 1995 Modelled IHME, GBD 2019 (accessed 2022)
146 (109 - 193) 1996 Modelled IHME, GBD 2019 (accessed 2022)
156 (116 - 208) 1999 Modelled IHME, GBD 2019 (accessed 2022)
150 (112 - 199) 1997 Modelled IHME, GBD 2019 (accessed 2022)
151 (112 - 200) 1998 Modelled IHME, GBD 2019 (accessed 2022)
152 (113 - 204) 2000 Modelled IHME, GBD 2019 (accessed 2022)
154 (114 - 206) 2001 Modelled IHME, GBD 2019 (accessed 2022)
158 (117 - 210) 2002 Modelled IHME, GBD 2019 (accessed 2022)
160 (118 - 214) 2003 Modelled IHME, GBD 2019 (accessed 2022)
161 (119 - 215) 2004 Modelled IHME, GBD 2019 (accessed 2022)
159 (118 - 215) 2005 Modelled IHME, GBD 2019 (accessed 2022)
164 (121 - 219) 2006 Modelled IHME, GBD 2019 (accessed 2022)
165 (122 - 222) 2007 Modelled IHME, GBD 2019 (accessed 2022)
165 (122 - 222) 2008 Modelled IHME, GBD 2019 (accessed 2022)
165 (122 - 220) 2009 Modelled IHME, GBD 2019 (accessed 2022)
161 (122 - 212) 2011 Modelled IHME, GBD 2019 (accessed 2022)
159 (121 - 208) 2012 Modelled IHME, GBD 2019 (accessed 2022)
165 (123 - 218) 2010 Modelled IHME, GBD 2019 (accessed 2022)
158 (120 - 208) 2013 Modelled IHME, GBD 2019 (accessed 2022)
153 (116 - 199) 2015 Modelled IHME, GBD 2019 (accessed 2022)
156 (119 - 206) 2014 Modelled IHME, GBD 2019 (accessed 2022)
154 (115 - 203) 2016 Modelled IHME, GBD 2019 (accessed 2022)
155 (117 - 202) 2017 Modelled IHME, GBD 2019 (accessed 2022)
156 (117 - 201) 2018 Modelled IHME, GBD 2019 (accessed 2022)
156 (118 - 203) 2019 Modelled IHME, GBD 2019 (accessed 2022)
156 (118 - 203) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
3 (2 - 5) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 5) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1998 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 6) 1999 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2000 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2002 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2001 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2003 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 7) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2007 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 2005 Modelled IHME, GBD 2019 (accessed 2022)
7 (4 - 9) 2008 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2009 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 12) 2011 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2010 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 2013 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 2012 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 14) 2015 Modelled IHME, GBD 2019 (accessed 2022)
10 (6 - 14) 2014 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 2016 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 2017 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 2018 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 12) 2019 Modelled IHME, GBD 2019 (accessed 2022)
13 (8 - 18) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.3 (0.30 - 0.30) 2015 Modelled Blach et al, 2017
0.88 (0.72 - 1.09) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.72 - 1.08) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.71 - 1.08) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.71 - 1.07) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.71 - 1.06) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.71 - 1.07) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.72 - 1.08) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.73 - 1.09) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.9 (0.73 - 1.10) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.74 - 1.11) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.74 - 1.10) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.9 (0.74 - 1.10) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.9 (0.74 - 1.09) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.73 - 1.09) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.73 - 1.09) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.73 - 1.08) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.73 - 1.07) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.73 - 1.07) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.72 - 1.07) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.72 - 1.06) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.72 - 1.06) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.72 - 1.06) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.72 - 1.06) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.72 - 1.06) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.71 - 1.06) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.71 - 1.06) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.70 - 1.05) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.70 - 1.04) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.69 - 1.03) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.68 - 1.02) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.67 - 1.01) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
60.73 2006 Survey/reported EMCDDA; Christensen et al. 2007
58 2005 Survey/reported EMCDDA; Christensen et al. 2008
67 2004 Survey/reported EMCDDA; Christensen et al. 2009
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.22 (0.16 - 0.22) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.7 (0.50 - 0.70) 2014 Modelled Gower et al, 2014
0.63 2019 Modelled Jin et al. 2017
Showing out of
Show more
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
3.1 (2.10 - 4.50) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
42.6 (36.10 - 49.10) 2011 Survey/reported Madsen LW et al, 2011
52.5 (45.70 - 59.20) 2008 Survey/reported EMCDDA
Showing out of
Show more
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
3.1 2019 Modelled Jin et al. 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
19,000 (14,000 - 20,000) 2015 Modelled Blach et al, 2017
39,993 (32,730 - 49,266) 1990 Modelled IHME, GBD 2019 (accessed 2022)
40,722 (33,339 - 50,037) 1991 Modelled IHME, GBD 2019 (accessed 2022)
41,384 (33,858 - 50,390) 1992 Modelled IHME, GBD 2019 (accessed 2022)
41,953 (34,287 - 50,917) 1993 Modelled IHME, GBD 2019 (accessed 2022)
42,425 (34,753 - 51,471) 1994 Modelled IHME, GBD 2019 (accessed 2022)
42,788 (35,039 - 52,035) 1995 Modelled IHME, GBD 2019 (accessed 2022)
43,064 (35,214 - 52,129) 1996 Modelled IHME, GBD 2019 (accessed 2022)
43,270 (35,588 - 52,155) 1997 Modelled IHME, GBD 2019 (accessed 2022)
43,447 (35,669 - 52,342) 1998 Modelled IHME, GBD 2019 (accessed 2022)
43,632 (35,820 - 52,781) 1999 Modelled IHME, GBD 2019 (accessed 2022)
43,864 (35,842 - 52,992) 2000 Modelled IHME, GBD 2019 (accessed 2022)
44,154 (36,281 - 53,442) 2001 Modelled IHME, GBD 2019 (accessed 2022)
44,429 (36,605 - 53,718) 2002 Modelled IHME, GBD 2019 (accessed 2022)
44,698 (36,774 - 54,104) 2003 Modelled IHME, GBD 2019 (accessed 2022)
44,971 (36,838 - 54,607) 2004 Modelled IHME, GBD 2019 (accessed 2022)
45,245 (36,926 - 55,253) 2005 Modelled IHME, GBD 2019 (accessed 2022)
45,556 (37,294 - 55,829) 2006 Modelled IHME, GBD 2019 (accessed 2022)
45,886 (37,642 - 56,019) 2007 Modelled IHME, GBD 2019 (accessed 2022)
46,219 (37,861 - 56,498) 2008 Modelled IHME, GBD 2019 (accessed 2022)
46,530 (37,895 - 56,716) 2009 Modelled IHME, GBD 2019 (accessed 2022)
46,789 (38,018 - 56,988) 2010 Modelled IHME, GBD 2019 (accessed 2022)
46,830 (38,123 - 56,799) 2011 Modelled IHME, GBD 2019 (accessed 2022)
46,570 (37,986 - 56,535) 2012 Modelled IHME, GBD 2019 (accessed 2022)
46,198 (37,707 - 56,472) 2013 Modelled IHME, GBD 2019 (accessed 2022)
45,915 (37,516 - 56,262) 2014 Modelled IHME, GBD 2019 (accessed 2022)
45,920 (37,341 - 56,292) 2015 Modelled IHME, GBD 2019 (accessed 2022)
46,443 (37,983 - 56,946) 2016 Modelled IHME, GBD 2019 (accessed 2022)
47,089 (38,472 - 57,634) 2017 Modelled IHME, GBD 2019 (accessed 2022)
47,580 (38,959 - 58,254) 2018 Modelled IHME, GBD 2019 (accessed 2022)
47,538 (38,725 - 58,812) 2019 Modelled IHME, GBD 2019 (accessed 2020)
48,034 (39,222 - 59,311) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
2,700 (2,000 - 2,700) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
4.98 (3.90 - 6.26) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.94 (3.11 - 5) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3.66 (2.89 - 4.65) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.77 (2.99 - 4.79) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4.15 (3.27 - 5.31) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4.43 (3.48 - 5.69) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4.59 (3.59 - 5.91) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4.65 (3.64 - 6.03) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4.77 (3.77 - 6.11) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4.75 (3.75 - 6.14) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4.9 (3.82 - 6.33) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4.78 (3.74 - 6.19) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4.84 (3.80 - 6.27) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4.9 (3.86 - 6.32) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4.92 (3.88 - 6.36) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4.92 (3.85 - 6.36) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5.01 (3.92 - 6.47) 2006 Modelled IHME, GBD 2019 (accessed 2022)
4.88 (3.84 - 6.28) 2005 Modelled IHME, GBD 2019 (accessed 2022)
5.07 (3.95 - 6.52) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5.1 (3.99 - 6.55) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5.16 (4.02 - 6.58) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5.21 (4.07 - 6.60) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5.16 (4.08 - 6.49) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5.16 (4.10 - 6.48) 2013 Modelled IHME, GBD 2019 (accessed 2022)
5.16 (4.08 - 6.51) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5.14 (4.08 - 6.41) 2014 Modelled IHME, GBD 2019 (accessed 2022)
5.06 (4.01 - 6.32) 2015 Modelled IHME, GBD 2019 (accessed 2022)
5.03 (3.99 - 6.29) 2016 Modelled IHME, GBD 2019 (accessed 2022)
5.02 (3.97 - 6.29) 2017 Modelled IHME, GBD 2019 (accessed 2022)
4.98 (3.90 - 6.26) 2019 Modelled IHME, GBD 2019 (accessed 2022)
5.01 (3.93 - 6.26) 2018 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
419 2016 Modelled WHO
289 (226 - 363) 2019 Modelled IHME, GBD 2019 (accessed 2022)
289 (226 - 363) 2019 Modelled IHME, GBD 2019 (accessed 2020)
289 (227 - 361) 2018 Modelled IHME, GBD 2019 (accessed 2022)
288 (228 - 361) 2017 Modelled IHME, GBD 2019 (accessed 2022)
287 (228 - 359) 2016 Modelled IHME, GBD 2019 (accessed 2022)
287 (227 - 359) 2015 Modelled IHME, GBD 2019 (accessed 2022)
290 (230 - 361) 2014 Modelled IHME, GBD 2019 (accessed 2022)
290 (230 - 363) 2013 Modelled IHME, GBD 2019 (accessed 2022)
288 (228 - 362) 2012 Modelled IHME, GBD 2019 (accessed 2022)
287 (227 - 362) 2011 Modelled IHME, GBD 2019 (accessed 2022)
288 (225 - 365) 2010 Modelled IHME, GBD 2019 (accessed 2022)
284 (222 - 363) 2009 Modelled IHME, GBD 2019 (accessed 2022)
280 (219 - 359) 2008 Modelled IHME, GBD 2019 (accessed 2022)
277 (216 - 356) 2007 Modelled IHME, GBD 2019 (accessed 2022)
273 (213 - 352) 2006 Modelled IHME, GBD 2019 (accessed 2022)
265 (208 - 341) 2005 Modelled IHME, GBD 2019 (accessed 2022)
266 (208 - 344) 2004 Modelled IHME, GBD 2019 (accessed 2022)
265 (209 - 343) 2003 Modelled IHME, GBD 2019 (accessed 2022)
263 (207 - 339) 2002 Modelled IHME, GBD 2019 (accessed 2022)
259 (203 - 336) 2001 Modelled IHME, GBD 2019 (accessed 2022)
255 (200 - 330) 2000 Modelled IHME, GBD 2019 (accessed 2022)
260 (203 - 337) 1999 Modelled IHME, GBD 2019 (accessed 2022)
252 (200 - 323) 1998 Modelled IHME, GBD 2019 (accessed 2022)
251 (197 - 324) 1997 Modelled IHME, GBD 2019 (accessed 2022)
244 (191 - 316) 1996 Modelled IHME, GBD 2019 (accessed 2022)
240 (188 - 309) 1995 Modelled IHME, GBD 2019 (accessed 2022)
231 (181 - 296) 1994 Modelled IHME, GBD 2019 (accessed 2022)
215 (170 - 276) 1993 Modelled IHME, GBD 2019 (accessed 2022)
204 (161 - 258) 1992 Modelled IHME, GBD 2019 (accessed 2022)
195 (154 - 247) 1991 Modelled IHME, GBD 2019 (accessed 2022)
188 (149 - 239) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
10 (8 - 13) 1992 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 12) 1990 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 1991 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 13) 1993 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 1994 Modelled IHME, GBD 2019 (accessed 2022)
11 (9 - 15) 1995 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 1996 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 1997 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 17) 1999 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 16) 1998 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 17) 2000 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 17) 2001 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 18) 2002 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 18) 2003 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 19) 2004 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 21) 2006 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 20) 2005 Modelled IHME, GBD 2019 (accessed 2022)
18 (14 - 23) 2008 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 21) 2007 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 25) 2009 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 27) 2010 Modelled IHME, GBD 2019 (accessed 2022)
26 (19 - 33) 2013 Modelled IHME, GBD 2019 (accessed 2022)
23 (17 - 29) 2011 Modelled IHME, GBD 2019 (accessed 2022)
25 (18 - 31) 2012 Modelled IHME, GBD 2019 (accessed 2022)
27 (20 - 34) 2014 Modelled IHME, GBD 2019 (accessed 2022)
27 (20 - 35) 2015 Modelled IHME, GBD 2019 (accessed 2022)
26 (19 - 34) 2016 Modelled IHME, GBD 2019 (accessed 2022)
26 (19 - 33) 2017 Modelled IHME, GBD 2019 (accessed 2022)
25 (18 - 32) 2019 Modelled IHME, GBD 2019 (accessed 2022)
25 (19 - 32) 2018 Modelled IHME, GBD 2019 (accessed 2022)
37 (27 - 47) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.89 (%)
2019
(0.74 - 1.05(%))
IHME, GBD 2019 (accessed 2020)
HCV (RNA/cAg+)
0.88 (%)
2019
(0.72 - 1.09(%))
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
156
2019
(118 - 203)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
289
2019
(226 - 363)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.68 (%)
2020, latest modelled
(0.59 - 0.79(%))
WHO

Prevalence PWID

HCV
42.60 (%)
2011, survey/surveillance
(36.10 - 49.10(%))
Madsen LW et al, 2011

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

News

Resources

Programs